Follow the 알피바이오 stock price and the full management transaction log of the company, a listed issuer based in South Korea. Shares are listed on KR KR, under the authority of DART (FSS). Operating in the Health Care sector, 알피바이오 has published 15 insider filings. The latest transaction was disclosed on 23 November 2023 (Purchase). Among the most active insiders: 마이다스제1호사모투자. All data is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
15 of 15 declarations
알피바이오 is a company in the health and pharmaceutical sector listed on the XKRX market. It focuses on developing innovative solutions in the biopharmaceutical field.